Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract

被引：67

作者：

Lautenbach, E

Harris, AD

Perencevich, EN

Nachamkin, I

Tolomeo, P

Metlay, JP

机构：

[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA

[2] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA

[3] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA

[4] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA

[5] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA

[6] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[7] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA

[8] Dept Vet Affairs, Philadelphia, PA USA

[9] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA

[10] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 02期

关键词：

D O I：

10.1128/AAC.49.2.798-800.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Among 63 patients enrolled in a prospective cohort study of gut colonization with fluoroquinolone-resistant Escherichia coli, the sensitivity of perirectal swab compared to stool sample was 90% (95% confidence interval [CI], 70 to 99%) and the specificity was 100% (95% CI, 91 to 100%). For rectal swab, the sensitivity was 90% (95% CI, 68 to 99%) and the specificity was 100% (95% CI, 91 to 100%).

引用

收藏

页码：798 / 800

页数：3

相关论文

共 11 条

[1] Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis [J].

Carratala, J ;

FernandezSevilla, A ;

Dominguez, FTMA ;

Gudiol, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :503-505

[2] High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci [J].

D'Agata, EMC ;

Gautam, S ;

Green, WK ;

Tang, YW .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (02) :167-172

[3] The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens [J].

Donskey, CJ .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :219-226

[4] Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001 [J].

Karlowsky, JA ;

Jones, ME ;

Thornsberry, C ;

Friedland, IR ;

Sahm, DF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) :1672-1680

[5] Longitudinal trends in fluoroquinolone resistance among enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: Differences in the emergence and epidemiology of resistance across organisms [J].

Lautenbach, E ;

Strom, BL ;

Nachamkin, I ;

Bilker, WB ;

Marr, AM ;

Larosa, LA ;

Fishman, NO .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :655-662

[6] Evaluation of VITEK 2 rapid identification and susceptibility testing system against Gram-negative clinical isolates [J].

Ling, TKW ;

Tam, PC ;

Liu, ZK ;

Cheng, AFB .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) :2964-2966

[7] SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus [J].

Muto, CA ;

Jernigan, JA ;

Ostrowsky, BE ;

Richet, HM ;

Jarvis, WR ;

Boyce, JM ;

Farr, BM .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (05) :362-386

[8] Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use [J].

Neuhauser, MM ;

Weinstein, RA ;

Rydman, R ;

Danziger, LH ;

Karam, G ;

Quinn, JP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (07) :885-888

[9]

Solomon S, 2003, AM J INFECT CONTROL, V31, P481

[10] Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients [J].

V. Baum H. ;

Franz U. ;

Geiss H.K. .

Infection, 2000, 28 (5) :278-281